A few days ago, the World Health Organization (WHO) stopped testing a drug hydroxychloroquine, a drug proposed by US President Donald Trump to treat the new novel coronavirus.
The agency announced that it had stopped using chloroquine to treat the corona virus because research had raised questions about its safety and even said it could increase the risk of death. I have increased.
The head of the World Health Organization (WHO), Tedros Adhanom Gabrias, has said that the World Health Organization (WHO) has “temporarily banned” chloroquine from a possible cure for the corona virus while reviewing safety data. ‘
Read Also:Is it possible to reverse premature hair whitening?
But now the World Health Organization has resumed trials of the drug.
This is due to questions raised in the study which said that the use of this drug increases the risk of death in patients with corona virus.
“We announced last week that we would temporarily suspend the trial of hydroxychloroquine, based on a few reports,” said Sumia Swamy Nathan, head of the World Health Organization’s team of scientists. It is said that this increases the death rate.
“Now we are confident and there is no difference in the death rate, so the Data Safety Monitoring Committee recommends resuming its trials,” he added.
Note that there is currently no cure or vaccine for Code 19 and hydroxychloroquine and remedies are being tested.
Sumia Swami Nathan said there was no evidence that any drug reduced the death rate in Code 19 patients.
“That’s why it’s so important to keep the trial going. The only way to get a final answer is to have a well-conducted trial, so we can see how deadly these drugs or strategies are to death and disease.” Are helpful in reducing.
It is believed that Donald Trump has been strongly supporting the use of hydroxychloroquine since the beginning of the spread of the corona virus in the United States, and even claimed in a press conference that the American Food and Drug Association has recommended the treatment of corona virus. Therefore, this medicine has been approved, which was later denied.
The US president later announced that he was using the drug himself and made the decision with the support of doctors and others.
“I think it’s a good thing and I’ve heard a lot of good stories about it,” he told reporters.
At the same time, he dismissed the dangers posed by chloroquine to his government’s experts.
Following the announcement by the World Health Organization to stop the trial of the drug, it was also announced to stop the trial of this drug in Pakistan.
The results of the largest study on the effects of hydroxychloroquine found that it was more likely to do harm than good.
About 15,000 people were treated with chloroquine (an older form of hydroxychloroquine), hydroxychloroquine, or both, with one antibiotic, while the rest were given none of these drugs as a control group. Worked out
In patients using these drugs, scientists discovered the risk of serious heartbeat disorders.
The researchers found that people who were given chloroquine or hydroxychloroquine had a 16 to 18 percent higher risk of dying in hospital than those who were not given the drug.
The study’s findings were published in The Lancet, and its editors have now raised concerns about its findings and questions about its data and statistics.
“We want to alert readers by the fact that serious scientific questions have come to our attention,” he said.
Read Also:5 Mental Stress Enhancing Habits That You Can Have
Although trials of the drug are now resuming and research findings are being called into question at the end of May, evidence of its effectiveness has yet to be established.
Evidence is constantly emerging that this drug is not as helpful as doctors expect.
A study of 1,300 patients at Columbia University’s Irwin Medical Center in the United States found that hydroxychloroquine did not reduce the need for ventilators, nor did it reduce the risk of death.
Research reports from Europe and China also show that patients do not benefit from the drug.
Following these reports, the US Food and Drug Administration (FDA) issued a statement saying that medical experts should not prescribe the drug for Code 19 and that it can only be used in research or in a hospital.